Aspirin Resistance: Clinical and Molecular Genetic Evaluation Techniques


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The article discusses the issues related to the personalization of preventive measures for ischemic stroke, in particular those associated with resistance to one of the most common antiplatelet drugs, aspirin. A brief historical note on investigation of acetylsalicylic acid is provided. The paper addresses the issue of etiological factors and epidemiology of aspirin resistance. An analysis and comparison of various techniques for evaluation of this phenomenon are performed. Separately, a molecular genetic aspect of the pathology is considered. In conclusion, the recommendations for overcoming tolerance to aspirin therapy are provided.

作者简介

M. Tanashyan

Research Center of Neurology

Email: rasckey@live.com
俄罗斯联邦, Moscow

M. Domashenko

Research Center of Neurology

Email: rasckey@live.com
俄罗斯联邦, Moscow

A. Raskurazhev

Research Center of Neurology

编辑信件的主要联系方式.
Email: rasckey@live.com
俄罗斯联邦, Moscow

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2017